These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 16227109

  • 1. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ, Alberta L, Robinson-Bostom L, Bostom A.
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [Abstract] [Full Text] [Related]

  • 2. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G, Dobmeyer J, Nissen H, Hansen TS.
    Am J Med Genet; 1996 Oct 16; 65(2):149-54. PubMed ID: 8911609
    [Abstract] [Full Text] [Related]

  • 3. [Hyperlipoproteinemia type III with apolipoprotein E phenotype 2/2].
    Engst R.
    Hautarzt; 1985 Nov 16; 36(11):629-34. PubMed ID: 4077508
    [Abstract] [Full Text] [Related]

  • 4. Molecular mechanisms of type III hyperlipoproteinemia: The contribution of the carboxy-terminal domain of ApoE can account for the dyslipidemia that is associated with the E2/E2 phenotype.
    Kypreos KE, Li X, van Dijk KW, Havekes LM, Zannis VI.
    Biochemistry; 2003 Aug 26; 42(33):9841-53. PubMed ID: 12924933
    [Abstract] [Full Text] [Related]

  • 5. Apolipoprotein E phenotype frequency in type II diabetic patients with different forms of hyperlipoproteinemia.
    Parhofer KG, Richter WO, Schwandt P.
    Horm Metab Res; 1990 Nov 26; 22(11):589-94. PubMed ID: 2272605
    [Abstract] [Full Text] [Related]

  • 6. [Severe type III hyperlipoproteinemia with unusual lipoprotein phenotype in an adolescent patient].
    Ziemer A, Göring HD.
    Hautarzt; 1993 Aug 26; 44(8):538-44. PubMed ID: 8376110
    [Abstract] [Full Text] [Related]

  • 7. Genetics of type III hyperlipoproteinemia.
    Feussner G, Piesch S, Dobmeyer J, Fischer C.
    Genet Epidemiol; 1997 Aug 26; 14(3):283-97. PubMed ID: 9181357
    [Abstract] [Full Text] [Related]

  • 8. Tuberous xanthomas associated with olanzapine therapy and hypertriglyceridemia in the setting of a rare apolipoprotein E mutation.
    Sinnott BP, Mazzone T.
    Endocr Pract; 2006 Aug 26; 12(2):183-7. PubMed ID: 16690468
    [Abstract] [Full Text] [Related]

  • 9. Apolipoprotein E2-Christchurch (136 Arg----Ser). New variant of human apolipoprotein E in a patient with type III hyperlipoproteinemia.
    Wardell MR, Brennan SO, Janus ED, Fraser R, Carrell RW.
    J Clin Invest; 1987 Aug 26; 80(2):483-90. PubMed ID: 3038959
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Apolipoprotein E phenotyping--useful in the study of hyperlipoproteinemia type III].
    Hagve TA, Furuset T, Christophersen B, Ose L.
    Tidsskr Nor Laegeforen; 1993 Mar 10; 113(7):853-6. PubMed ID: 8480294
    [Abstract] [Full Text] [Related]

  • 12. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L, de Wit E, Leuven JG, Klasen E, Utermann G, Weber W, Beisiegel U.
    Hum Genet; 1986 Jun 10; 73(2):157-63. PubMed ID: 3721502
    [Abstract] [Full Text] [Related]

  • 13. Apolipoprotein E (role in lipoprotein metabolism and pathophysiology of hyperlipoproteinemia type III).
    Utermann G.
    Ric Clin Lab; 1982 Jun 10; 12(1):23-30. PubMed ID: 6283616
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD, Novoselov AV, Visvikis S, Siest G, Yakushkin VV, Tsibulsky V.
    Biol Chem; 2005 May 10; 386(5):441-52. PubMed ID: 15927888
    [Abstract] [Full Text] [Related]

  • 17. Dysbetalipoproteinaemia--clinical and pathophysiological features.
    Blom DJ, Byrnes P, Jones S, Marais AD.
    S Afr Med J; 2002 Nov 10; 92(11):892-7. PubMed ID: 12506591
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.